APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pimavanserin Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pimavanserin Drugs Market Analysis and Forecast 2026-2032

27 December 2025191 pages

Choose your research edition.

Industry ResearchPimavanserin Drugs Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal Pimavanserin Drugs Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal Pimavanserin Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032173 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pimavanserin Drugs Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Pimavanserin Drugs Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Pimavanserin Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pimavanserin Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pimavanserin Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pimavanserin Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pimavanserin Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Pimavanserin Drugs include Zydus Pharmaceuticals, MSN Laboratories, Hetero Labs and Acadia Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pimavanserin Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pimavanserin Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Pimavanserin Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pimavanserin Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pimavanserin Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pimavanserin Drugs sales, projected growth trends, production technology, application and end-user industry.

Pimavanserin Drugs Segment by Company

Zydus Pharmaceuticals

MSN Laboratories

Hetero Labs

Acadia Pharmaceuticals

Pimavanserin Drugs Segment by Type

Tablets

Capsules

Pimavanserin Drugs Segment by Application

Hospital and Clinic

Pharmacy

Other

Pimavanserin Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pimavanserin Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pimavanserin Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pimavanserin Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pimavanserin Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pimavanserin Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pimavanserin Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pimavanserin Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Tablets Major Manufacturers Table 3. Capsules Major Manufacturers Table 4. Global Pimavanserin Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital and Clinic Major Manufacturers Table 6. Pharmacy Major Manufacturers Table 7. Other Major Manufacturers Table 8. Pimavanserin Drugs Industry Trends Table 9. Pimavanserin Drugs Industry Drivers Table 10. Pimavanserin Drugs Industry Opportunities and Challenges Table 11. Pimavanserin Drugs Industry Restraints Table 12. Global Pimavanserin Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Pimavanserin Drugs Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Pimavanserin Drugs Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Pimavanserin Drugs Revenue Market Share by Region (2021-2026) Table 16. Global Pimavanserin Drugs Revenue Market Share by Region (2027-2032) Table 17. Global Pimavanserin Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Pimavanserin Drugs Sales by Region (2021-2026) & (K Units) Table 19. Global Pimavanserin Drugs Sales by Region (2027-2032) & (K Units) Table 20. Global Pimavanserin Drugs Sales Market Share by Region (2021-2026) Table 21. Global Pimavanserin Drugs Sales Market Share by Region (2027-2032) Table 22. Global Pimavanserin Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Pimavanserin Drugs Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Pimavanserin Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Pimavanserin Drugs Sales Market Share by Manufacturers (2021-2026) Table 26. Global Pimavanserin Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Pimavanserin Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Pimavanserin Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Pimavanserin Drugs Manufacturers, Product Type & Application Table 30. Global Pimavanserin Drugs Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Pimavanserin Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Pimavanserin Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Pimavanserin Drugs Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Pimavanserin Drugs Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Pimavanserin Drugs Revenue Market Share by Type (2021-2026) Table 37. Global Pimavanserin Drugs Revenue Market Share by Type (2027-2032) Table 38. Global Pimavanserin Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Pimavanserin Drugs Sales by Type (2021-2026) & (K Units) Table 40. Global Pimavanserin Drugs Sales by Type (2027-2032) & (K Units) Table 41. Global Pimavanserin Drugs Sales Market Share by Type (2021-2026) Table 42. Global Pimavanserin Drugs Sales Market Share by Type (2027-2032) Table 43. Global Pimavanserin Drugs Price by Type (2021-2026) & (US$/Unit) Table 44. Global Pimavanserin Drugs Price by Type (2027-2032) & (US$/Unit) Table 45. Global Pimavanserin Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Pimavanserin Drugs Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Pimavanserin Drugs Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Pimavanserin Drugs Revenue Market Share by Application (2021-2026) Table 49. Global Pimavanserin Drugs Revenue Market Share by Application (2027-2032) Table 50. Global Pimavanserin Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Pimavanserin Drugs Sales by Application (2021-2026) & (K Units) Table 52. Global Pimavanserin Drugs Sales by Application (2027-2032) & (K Units) Table 53. Global Pimavanserin Drugs Sales Market Share by Application (2021-2026) Table 54. Global Pimavanserin Drugs Sales Market Share by Application (2027-2032) Table 55. Global Pimavanserin Drugs Price by Application (2021-2026) & (US$/Unit) Table 56. Global Pimavanserin Drugs Price by Application (2027-2032) & (US$/Unit) Table 57. Zydus Pharmaceuticals Company Information Table 58. Zydus Pharmaceuticals Business Overview Table 59. Zydus Pharmaceuticals Pimavanserin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Zydus Pharmaceuticals Pimavanserin Drugs Product Portfolio Table 61. Zydus Pharmaceuticals Recent Development Table 62. MSN Laboratories Company Information Table 63. MSN Laboratories Business Overview Table 64. MSN Laboratories Pimavanserin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. MSN Laboratories Pimavanserin Drugs Product Portfolio Table 66. MSN Laboratories Recent Development Table 67. Hetero Labs Company Information Table 68. Hetero Labs Business Overview Table 69. Hetero Labs Pimavanserin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Hetero Labs Pimavanserin Drugs Product Portfolio Table 71. Hetero Labs Recent Development Table 72. Acadia Pharmaceuticals Company Information Table 73. Acadia Pharmaceuticals Business Overview Table 74. Acadia Pharmaceuticals Pimavanserin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Acadia Pharmaceuticals Pimavanserin Drugs Product Portfolio Table 76. Acadia Pharmaceuticals Recent Development Table 77. North America Pimavanserin Drugs Revenue by Type (2021-2026) & (US$ Million) Table 78. North America Pimavanserin Drugs Revenue by Type (2027-2032) & (US$ Million) Table 79. North America Pimavanserin Drugs Sales by Type (2021-2026) & (K Units) Table 80. North America Pimavanserin Drugs Sales by Type (2027-2032) & (K Units) Table 81. North America Pimavanserin Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 82. North America Pimavanserin Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 83. North America Pimavanserin Drugs Revenue by Application (2021-2026) & (US$ Million) Table 84. North America Pimavanserin Drugs Revenue by Application (2027-2032) & (US$ Million) Table 85. North America Pimavanserin Drugs Sales by Application (2021-2026) & (K Units) Table 86. North America Pimavanserin Drugs Sales by Application (2027-2032) & (K Units) Table 87. North America Pimavanserin Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 88. North America Pimavanserin Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 89. North America Pimavanserin Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America Pimavanserin Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 91. North America Pimavanserin Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 92. North America Pimavanserin Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 93. North America Pimavanserin Drugs Sales by Country (2021-2026) & (K Units) Table 94. North America Pimavanserin Drugs Sales by Country (2027-2032) & (K Units) Table 95. North America Pimavanserin Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 96. North America Pimavanserin Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 97. United States Pimavanserin Drugs Revenue (2021-2032) & (US$ Million) Table 98. Canada Pimavanserin Drugs Revenue (2021-2032) & (US$ Million) Table 99. Mexico Pimavanserin Drugs Revenue (2021-2032) & (US$ Million) Table 100. Europe Pimavanserin Drugs Revenue by Type (2021-2026) & (US$ Million) Table 101. Europe Pimavanserin Drugs Revenue by Type (2027-2032) & (US$ Million) Table 102. Europe Pimavanserin Drugs Sales by Type (2021-2026) & (K Units) Table 103. Europe Pimavanserin Drugs Sales by Type (2027-2032) & (K Units) Table 104. Europe Pimavanserin Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 105. Europe Pimavanserin Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 106. Europe Pimavanserin Drugs Revenue by Application (2021-2026) & (US$ Million) Table 107. Europe Pimavanserin Drugs Revenue by Application (2027-2032) & (US$ Million) Table 108. Europe Pimavanserin Drugs Sales by Application (2021-2026) & (K Units) Table 109. Europe Pimavanserin Drugs Sales by Application (2027-2032) & (K Units) Table 110. Europe Pimavanserin Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 111. Europe Pimavanserin Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 112. Europe Pimavanserin Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Europe Pimavanserin Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 114. Europe Pimavanserin Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 115. Europe Pimavanserin Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 116. Europe Pimavanserin Drugs Sales by Country (2021-2026) & (K Units) Table 117. Europe Pimavanserin Drugs Sales by Country (2027-2032) & (K Units) Table 118. Europe Pimavanserin Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 119. Europe Pimavanserin Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 120. Germany Pimavanserin Drugs Revenue (2021-2032) & (US$ Million) Table 121. France Pimavanserin Drugs Revenue (2021-2032) & (US$ Million) Table 122. U.K. Pimavanserin Drugs Revenue (2021-2032) & (US$ Million) Table 123. Italy Pimavanserin Drugs Revenue (2021-2032) & (US$ Million) Table 124. Russia Pimavanserin Drugs Revenue (2021-2032) & (US$ Million) Table 125. Spain Pimavanserin Drugs Revenue (2021-2032) & (US$ Million) Table 126. Netherlands Pimavanserin Drugs Revenue (2021-2032) & (US$ Million) Table 127. Switzerland Pimavanserin Drugs Revenue (2021-2032) & (US$ Million) Table 128. Sweden Pimavanserin Drugs Revenue (2021-2032) & (US$ Million) Table 129. Poland Pimavanserin Drugs Revenue (2021-2032) & (US$ Million) Table 130. China Pimavanserin Drugs Revenue by Type (2021-2026) & (US$ Million) Table 131. China Pimavanserin Drugs Revenue by Type (2027-2032) & (US$ Million) Table 132. China Pimavanserin Drugs Sales by Type (2021-2026) & (K Units) Table 133. China Pimavanserin Drugs Sales by Type (2027-2032) & (K Units) Table 134. China Pimavanserin Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 135. China Pimavanserin Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 136. China Pimavanserin Drugs Revenue by Application (2021-2026) & (US$ Million) Table 137. China Pimavanserin Drugs Revenue by Application (2027-2032) & (US$ Million) Table 138. China Pimavanserin Drugs Sales by Application (2021-2026) & (K Units) Table 139. China Pimavanserin Drugs Sales by Application (2027-2032) & (K Units) Table 140. China Pimavanserin Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 141. China Pimavanserin Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 142. Asia Pimavanserin Drugs Revenue by Type (2021-2026) & (US$ Million) Table 143. Asia Pimavanserin Drugs Revenue by Type (2027-2032) & (US$ Million) Table 144. Asia Pimavanserin Drugs Sales by Type (2021-2026) & (K Units) Table 145. Asia Pimavanserin Drugs Sales by Type (2027-2032) & (K Units) Table 146. Asia Pimavanserin Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 147. Asia Pimavanserin Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 148. Asia Pimavanserin Drugs Revenue by Application (2021-2026) & (US$ Million) Table 149. Asia Pimavanserin Drugs Revenue by Application (2027-2032) & (US$ Million) Table 150. Asia Pimavanserin Drugs Sales by Application (2021-2026) & (K Units) Table 151. Asia Pimavanserin Drugs Sales by Application (2027-2032) & (K Units) Table 152. Asia Pimavanserin Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 153. Asia Pimavanserin Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 154. Asia Pimavanserin Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. Asia Pimavanserin Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 156. Asia Pimavanserin Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 157. Asia Pimavanserin Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 158. Asia Pimavanserin Drugs Sales by Country (2021-2026) & (K Units) Table 159. Asia Pimavanserin Drugs Sales by Country (2027-2032) & (K Units) Table 160. Asia Pimavanserin Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 161. Asia Pimavanserin Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 162. Japan Pimavanserin Drugs Revenue (2021-2032) & (US$ Million) Table 163. South Korea Pimavanserin Drugs Revenue (2021-2032) & (US$ Million) Table 164. India Pimavanserin Drugs Revenue (2021-2032) & (US$ Million) Table 165. Australia Pimavanserin Drugs Revenue (2021-2032) & (US$ Million) Table 166. Taiwan Pimavanserin Drugs Revenue (2021-2032) & (US$ Million) Table 167. Southeast Asia Pimavanserin Drugs Revenue (2021-2032) & (US$ Million) Table 168. SAMEA Pimavanserin Drugs Revenue by Type (2021-2026) & (US$ Million) Table 169. SAMEA Pimavanserin Drugs Revenue by Type (2027-2032) & (US$ Million) Table 170. SAMEA Pimavanserin Drugs Sales by Type (2021-2026) & (K Units) Table 171. SAMEA Pimavanserin Drugs Sales by Type (2027-2032) & (K Units) Table 172. SAMEA Pimavanserin Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 173. SAMEA Pimavanserin Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 174. SAMEA Pimavanserin Drugs Revenue by Application (2021-2026) & (US$ Million) Table 175. SAMEA Pimavanserin Drugs Revenue by Application (2027-2032) & (US$ Million) Table 176. SAMEA Pimavanserin Drugs Sales by Application (2021-2026) & (K Units) Table 177. SAMEA Pimavanserin Drugs Sales by Application (2027-2032) & (K Units) Table 178. SAMEA Pimavanserin Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 179. SAMEA Pimavanserin Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 180. SAMEA Pimavanserin Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 181. SAMEA Pimavanserin Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 182. SAMEA Pimavanserin Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 183. SAMEA Pimavanserin Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 184. SAMEA Pimavanserin Drugs Sales by Country (2021-2026) & (K Units) Table 185. SAMEA Pimavanserin Drugs Sales by Country (2027-2032) & (K Units) Table 186. SAMEA Pimavanserin Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 187. SAMEA Pimavanserin Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 188. Brazil Pimavanserin Drugs Revenue (2021-2032) & (US$ Million) Table 189. Argentina Pimavanserin Drugs Revenue (2021-2032) & (US$ Million) Table 190. Chile Pimavanserin Drugs Revenue (2021-2032) & (US$ Million) Table 191. Colombia Pimavanserin Drugs Revenue (2021-2032) & (US$ Million) Table 192. Peru Pimavanserin Drugs Revenue (2021-2032) & (US$ Million) Table 193. Saudi Arabia Pimavanserin Drugs Revenue (2021-2032) & (US$ Million) Table 194. Israel Pimavanserin Drugs Revenue (2021-2032) & (US$ Million) Table 195. UAE Pimavanserin Drugs Revenue (2021-2032) & (US$ Million) Table 196. Turkey Pimavanserin Drugs Revenue (2021-2032) & (US$ Million) Table 197. Iran Pimavanserin Drugs Revenue (2021-2032) & (US$ Million) Table 198. Egypt Pimavanserin Drugs Revenue (2021-2032) & (US$ Million) Table 199. Key Raw Materials Table 200. Raw Materials Key Suppliers Table 201. Pimavanserin Drugs Distributors List Table 202. Pimavanserin Drugs Customers List Table 203. Research Programs/Design for This Report Table 204. Authors List of This Report Table 205. Secondary Sources Table 206. Primary Sources List of Figures Figure 1. Pimavanserin Drugs Image Figure 2. Global Pimavanserin Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pimavanserin Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Tablets Image Figure 5. Capsules Image Figure 6. Global Pimavanserin Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Pimavanserin Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital and Clinic Image Figure 9. Pharmacy Image Figure 10. Other Image Figure 11. Global Pimavanserin Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Pimavanserin Drugs Revenue (2021-2032) & (US$ Million) Figure 13. Global Pimavanserin Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Pimavanserin Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Pimavanserin Drugs Revenue Market Share by Region (2021-2032) Figure 16. Global Pimavanserin Drugs Sales (2021-2032) & (K Units) Figure 17. Global Pimavanserin Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Pimavanserin Drugs Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Pimavanserin Drugs Sales YoY (2021-2032) & (K Units) Figure 20. Europe Pimavanserin Drugs Sales YoY (2021-2032) & (K Units) Figure 21. China Pimavanserin Drugs Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Pimavanserin Drugs Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Pimavanserin Drugs Sales YoY (2021-2032) & (K Units) Figure 24. Global Pimavanserin Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Pimavanserin Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Pimavanserin Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Pimavanserin Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Pimavanserin Drugs Revenue Market Share by Type (2021-2032) Figure 30. Global Pimavanserin Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Pimavanserin Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Pimavanserin Drugs Sales Market Share by Type (2021-2032) Figure 33. Global Pimavanserin Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Pimavanserin Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Pimavanserin Drugs Revenue Market Share by Application (2021-2032) Figure 36. Global Pimavanserin Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Pimavanserin Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Pimavanserin Drugs Sales Market Share by Application (2021-2032) Figure 39. North America Pimavanserin Drugs Revenue Share by Type (2021-2032) Figure 40. North America Pimavanserin Drugs Sales Share by Type (2021-2032) Figure 41. North America Pimavanserin Drugs Revenue Share by Application (2021-2032) Figure 42. North America Pimavanserin Drugs Sales Share by Application (2021-2032) Figure 43. North America Pimavanserin Drugs Revenue Share by Country (2021-2032) Figure 44. North America Pimavanserin Drugs Sales Share by Country (2021-2032) Figure 45. Europe Pimavanserin Drugs Revenue Share by Type (2021-2032) Figure 46. Europe Pimavanserin Drugs Sales Share by Type (2021-2032) Figure 47. Europe Pimavanserin Drugs Revenue Share by Application (2021-2032) Figure 48. Europe Pimavanserin Drugs Sales Share by Application (2021-2032) Figure 49. Europe Pimavanserin Drugs Revenue Share by Country (2021-2032) Figure 50. Europe Pimavanserin Drugs Sales Share by Country (2021-2032) Figure 51. China Pimavanserin Drugs Revenue Share by Type (2021-2032) Figure 52. China Pimavanserin Drugs Sales Share by Type (2021-2032) Figure 53. China Pimavanserin Drugs Revenue Share by Application (2021-2032) Figure 54. China Pimavanserin Drugs Sales Share by Application (2021-2032) Figure 55. Asia Pimavanserin Drugs Revenue Share by Type (2021-2032) Figure 56. Asia Pimavanserin Drugs Sales Share by Type (2021-2032) Figure 57. Asia Pimavanserin Drugs Revenue Share by Application (2021-2032) Figure 58. Asia Pimavanserin Drugs Sales Share by Application (2021-2032) Figure 59. Asia Pimavanserin Drugs Revenue Share by Country (2021-2032) Figure 60. Asia Pimavanserin Drugs Sales Share by Country (2021-2032) Figure 61. SAMEA Pimavanserin Drugs Revenue Share by Type (2021-2032) Figure 62. SAMEA Pimavanserin Drugs Sales Share by Type (2021-2032) Figure 63. SAMEA Pimavanserin Drugs Revenue Share by Application (2021-2032) Figure 64. SAMEA Pimavanserin Drugs Sales Share by Application (2021-2032) Figure 65. SAMEA Pimavanserin Drugs Revenue Share by Country (2021-2032) Figure 66. SAMEA Pimavanserin Drugs Sales Share by Country (2021-2032) Figure 67. Pimavanserin Drugs Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Pimavanserin Drugs Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Capsules
Applications
  • Hospital and Clinic
  • Pharmacy
  • Other
Companies covered
  • Zydus Pharmaceuticals
  • MSN Laboratories
  • Hetero Labs
  • Acadia Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pimavanserin Drugs Market by Type
  3. 1.2.1 Global Pimavanserin Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Tablets
  5. 1.2.3 Capsules
  6. 1.3 Pimavanserin Drugs Market by Application
  7. 1.3.1 Global Pimavanserin Drugs Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital and Clinic
  9. 1.3.3 Pharmacy
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Pimavanserin Drugs Market Dynamics
  1. 2.1 Pimavanserin Drugs Industry Trends
  2. 2.2 Pimavanserin Drugs Industry Drivers
  3. 2.3 Pimavanserin Drugs Industry Opportunities and Challenges
  4. 2.4 Pimavanserin Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pimavanserin Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pimavanserin Drugs Revenue by Region
  3. 3.2.1 Global Pimavanserin Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pimavanserin Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Pimavanserin Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Pimavanserin Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pimavanserin Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pimavanserin Drugs Sales by Region
  9. 3.4.1 Global Pimavanserin Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pimavanserin Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Pimavanserin Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Pimavanserin Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pimavanserin Drugs Revenue by Manufacturers
  2. 4.1.1 Global Pimavanserin Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pimavanserin Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pimavanserin Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pimavanserin Drugs Sales by Manufacturers
  6. 4.2.1 Global Pimavanserin Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pimavanserin Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pimavanserin Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pimavanserin Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pimavanserin Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pimavanserin Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pimavanserin Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Pimavanserin Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pimavanserin Drugs Market CR5 and HHI
  16. 4.8.2 2025 Pimavanserin Drugs Tier 1, Tier 2, and Tier 3
5 Pimavanserin Drugs Market by Type
  1. 5.1 Global Pimavanserin Drugs Revenue by Type
  2. 5.1.1 Global Pimavanserin Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pimavanserin Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pimavanserin Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pimavanserin Drugs Sales by Type
  6. 5.2.1 Global Pimavanserin Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pimavanserin Drugs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Pimavanserin Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pimavanserin Drugs Price by Type
6 Pimavanserin Drugs Market by Application
  1. 6.1 Global Pimavanserin Drugs Revenue by Application
  2. 6.1.1 Global Pimavanserin Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pimavanserin Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pimavanserin Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pimavanserin Drugs Sales by Application
  6. 6.2.1 Global Pimavanserin Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pimavanserin Drugs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Pimavanserin Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pimavanserin Drugs Price by Application
7 Company Profiles
  1. 7.1 Zydus Pharmaceuticals
  2. 7.1.1 Zydus Pharmaceuticals Company Information
  3. 7.1.2 Zydus Pharmaceuticals Business Overview
  4. 7.1.3 Zydus Pharmaceuticals Pimavanserin Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Zydus Pharmaceuticals Pimavanserin Drugs Product Portfolio
  6. 7.1.5 Zydus Pharmaceuticals Recent Developments
  7. 7.2 MSN Laboratories
  8. 7.2.1 MSN Laboratories Company Information
  9. 7.2.2 MSN Laboratories Business Overview
  10. 7.2.3 MSN Laboratories Pimavanserin Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 MSN Laboratories Pimavanserin Drugs Product Portfolio
  12. 7.2.5 MSN Laboratories Recent Developments
  13. 7.3 Hetero Labs
  14. 7.3.1 Hetero Labs Company Information
  15. 7.3.2 Hetero Labs Business Overview
  16. 7.3.3 Hetero Labs Pimavanserin Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Hetero Labs Pimavanserin Drugs Product Portfolio
  18. 7.3.5 Hetero Labs Recent Developments
  19. 7.4 Acadia Pharmaceuticals
  20. 7.4.1 Acadia Pharmaceuticals Company Information
  21. 7.4.2 Acadia Pharmaceuticals Business Overview
  22. 7.4.3 Acadia Pharmaceuticals Pimavanserin Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Acadia Pharmaceuticals Pimavanserin Drugs Product Portfolio
  24. 7.4.5 Acadia Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Pimavanserin Drugs Market Size by Type
  2. 8.1.1 North America Pimavanserin Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Pimavanserin Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Pimavanserin Drugs Price by Type (2021-2032)
  5. 8.2 North America Pimavanserin Drugs Market Size by Application
  6. 8.2.1 North America Pimavanserin Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Pimavanserin Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Pimavanserin Drugs Price by Application (2021-2032)
  9. 8.3 North America Pimavanserin Drugs Market Size by Country
  10. 8.3.1 North America Pimavanserin Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pimavanserin Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pimavanserin Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Pimavanserin Drugs Market Size by Type
  2. 9.1.1 Europe Pimavanserin Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pimavanserin Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Pimavanserin Drugs Price by Type (2021-2032)
  5. 9.2 Europe Pimavanserin Drugs Market Size by Application
  6. 9.2.1 Europe Pimavanserin Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pimavanserin Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Pimavanserin Drugs Price by Application (2021-2032)
  9. 9.3 Europe Pimavanserin Drugs Market Size by Country
  10. 9.3.1 Europe Pimavanserin Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pimavanserin Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pimavanserin Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Pimavanserin Drugs Market Size by Type
  2. 10.1.1 China Pimavanserin Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Pimavanserin Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Pimavanserin Drugs Price by Type (2021-2032)
  5. 10.2 China Pimavanserin Drugs Market Size by Application
  6. 10.2.1 China Pimavanserin Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Pimavanserin Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Pimavanserin Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pimavanserin Drugs Market Size by Type
  2. 11.1.1 Asia Pimavanserin Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pimavanserin Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Pimavanserin Drugs Price by Type (2021-2032)
  5. 11.2 Asia Pimavanserin Drugs Market Size by Application
  6. 11.2.1 Asia Pimavanserin Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pimavanserin Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Pimavanserin Drugs Price by Application (2021-2032)
  9. 11.3 Asia Pimavanserin Drugs Market Size by Country
  10. 11.3.1 Asia Pimavanserin Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pimavanserin Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pimavanserin Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pimavanserin Drugs Market Size by Type
  2. 12.1.1 SAMEA Pimavanserin Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pimavanserin Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pimavanserin Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Pimavanserin Drugs Market Size by Application
  6. 12.2.1 SAMEA Pimavanserin Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pimavanserin Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pimavanserin Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Pimavanserin Drugs Market Size by Country
  10. 12.3.1 SAMEA Pimavanserin Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pimavanserin Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pimavanserin Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pimavanserin Drugs Value Chain Analysis
  2. 13.1.1 Pimavanserin Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pimavanserin Drugs Production Mode & Process
  6. 13.2 Pimavanserin Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pimavanserin Drugs Distributors
  9. 13.2.3 Pimavanserin Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst